Previous Article | Next Article ![]()
Infection and Immunity, July 1999, p. 3625-3630, Vol. 67, No. 7
Departments of
Medicine1 and of Microbiology and
Immunology,3 University of California, San
Francisco, San Francisco, California 94143, and Centre for
Molecular and Cellular Biology, The University of Queensland,
Brisbane, Queensland 4072, Australia2
Received 9 February 1999/Returned for modification 23 March
1999/Accepted 9 April 1999
Type IV pili of the opportunistic pathogen Pseudomonas
aeruginosa mediate twitching motility and act as receptors for
bacteriophage infection. They are also important bacterial adhesins,
and nonpiliated mutants of P. aeruginosa have been shown to
cause less epithelial cell damage in vitro and have decreased virulence
in animal models. This finding raises the question as to whether the
reduction in cytotoxicity and virulence of nonpiliated P. aeruginosa mutants are primarily due to defects in cell adhesion
or loss of twitching motility, or both. This work describes the role of
PilT and PilU, putative nucleotide-binding proteins involved in pili
function, in mediating epithelial cell injury in vitro and virulence in vivo. Mutants of pilT and pilU retain surface
pili but have lost twitching motility. In three different epithelial
cell lines, pilT or pilU mutants of the strain
PAK caused less cytotoxicity than the wild-type strain but more than
isogenic, nonpiliated pilA or rpoN mutants. The
pilT and pilU mutants also showed reduced association with these same epithelial cell lines compared both to the
wild type, and surprisingly, to a pilA mutant. In a mouse model of acute pneumonia, the pilT and pilU
mutants showed decreased colonization of the liver but not of the lung
relative to the parental strain, though they exhibited no change in the
ability to cause mortality. These results demonstrate that pilus
function mediated by PilT and PilU is required for in vitro adherence
and cytotoxicity toward epithelial cells and is important in virulence in vivo.
Type IV pili of Pseudomonas
aeruginosa are significant adhesins for interaction with mammalian
cells (reviewed in references 15 and
25), contributing to this organism's ability to
cause opportunistic infections in humans. They also are required for motility of the bacteria across a solid surface (twitching motility) (8) and for the binding and entry of bacteriophages (6, 7). P. aeruginosa pili are polymers of a single gene
product, called PilA or pilin (32), but their assembly and
function requires the products of at least 30 additional genes
(reviewed in reference 1). Three of these genes,
pilB, pilT, and pilU, encode proteins that contain motifs common among nucleotide-binding proteins (Walker box A domains [37]) and thus are postulated to
contribute energy to pili formation or function (1, 18, 40).
Inactivation of pilB results in a nonpiliated phenotype
(24), while strains with defects in pilT or
pilU overexpress surface pili but are no longer motile on a
solid surface (10, 40). These observations, in addition to
electron microscopy studies comparing phage binding of pilT
mutant and wild-type strains (9), suggested that PilB enables pili extension whereas PilT and PilU catalyze pili retraction (15, 23). However, the precise functions of PilT and PilU in
this process remain obscure, and pilU mutants, unlike
pilT mutants, remain sensitive to bacteriophage infection
(40). The proposed dynamic nature of pili could promote the
entry of bacteriophage into the bacterium and provide the impetus for
twitching motility, but its importance in P. aeruginosa
adherence to mammalian cells and virulence has not been examined.
Importantly, since pilT and pilU mutants retain
(hyper)expression of surface pili, such mutants provide an opportunity
to dissect the role of pili as adhesins and as the mediators of
twitching motility in the process of P. aeruginosa
infection. This may be also relevant to infection caused by a wide
range of other type IV piliated bacteria, including Neisseria spp., Moraxella spp.,
Aeromonas spp., and Legionella spp. (4, 22,
30, 35, 41).
The pilT and pilU genes are contiguous on the
P. aeruginosa chromosome but reside in a locus separated
from other genes involved in pilus biogenesis and function. Northern
blot and complementation analyses suggest that the two genes are
transcribed independently and thus are not part of the same operon
(40). The encoded proteins are closely related to each other
(39% amino acid identity and 61% similarity) but are more distantly
related to PilB and to other putative bacterial nucleotide-binding
proteins involved in fimbrial biogenesis, protein secretion, or DNA
transfer (39, 40). Direct homologs of PilT that are involved
in type IV pili function have been identified in enteropathogenic
Escherichia coli (EPEC) (31), Myxococcus
xanthus (43), and Neisseria gonorrheae (11). Examination of the unfinished genome sequences of
N. gonorrhoeae and N. meningitidis indicates that
these species at least also contain homologs of PilU (40a).
An EPEC mutant defective in the pilT-like bfpF
gene, despite having morphologically wild-type bundle-forming pili,
displayed increased adherence to epithelial cells in culture, formed
irregular bacterial aggregates, and had decreased virulence in humans
(2, 5). An in-frame deletion of the M. xanthus
pilT gene did not affect the expression of pili or cell to cell
agglutination but did cause a loss of pilus-dependent social gliding
motility (43). Furthermore, the natural competence and
twitching motility of a N. gonorrhea pilT mutant were
abolished, but this strain retained wild-type pilus expression and
adherence to epithelial cells (41-43). Inactivation of
pilT was also shown to rescue the pilus production defect of
pilC mutants, further demonstrating a role for N. gonorrheae PilT in pilus function (42).
A number of studies have implicated P. aeruginosa pili as
factors important for adherence to epithelial cells in vitro (reviewed in references 15 and 25) and for
virulence at several sites of infection (13, 14, 27). These
studies have all used nonpiliated mutants of P. aeruginosa
except for one investigation which demonstrated that a pilT
mutant of P. aeruginosa PAO (DB2) and two other
hyperpiliated isolates were noninfectious in a mouse corneal infection
model (17). This study suggested that the presence of pili
(as adhesins) per se is insufficient to support virulence in vivo. Here
we sought to examine further the importance of PilT and PilU in causing epithelial cell injury in vitro and in vivo by comparing the adherence, cytotoxicity, and virulence of the parental strain PAK to those of
isogenic pilT and pilU mutants and of isogenic
nonpiliated strains.
PilT and PilU contribute to PAK-mediated cytotoxicity toward
multiple epithelial cell lines.
Previous studies have demonstrated
that the addition of P. aeruginosa PAK to the apical surface
of a highly polarized epithelial cell monolayer consisting of
Madin-Darby canine kidney (MDCK) cells resulted in significant
cytotoxicity in vitro (3). Comparison of isogenic mutants
and different strains demonstrated that the amount of cell damage
observed in vitro correlated well to relative virulence in an animal
model of acute pneumonia (16, 28). We used this MDCK system
to determine if PilT or PilU were required for cytotoxicity in vitro.
MDCK type II cells (5 × 106) were grown as a
confluent monolayer on Transwell filters (Corning) for 3 days as
previously described (20), washed, and placed in minimal
essential medium Eagle (MEM) supplemented with 20 mM HEPES buffer pH
7.4 (MEM-lite). Approximately 107 CFU (as determined by
dilution plating) of a stationary-phase culture of PAK wild-type or
isogenic mutant strain (Table 1) grown
for 16 h in Luria broth without shaking at 37°C was added to the
apical surface of the MDCK cell monolayer (multiplicity of infection of
2). After incubation for 9 h at 37°C in room air, aliquots of
the apical and basal medium were removed and assayed for lactate
dehydrogenase (LDH) activity as instructed by the manufacturer (Sigma
Chemical Co.). The percentage of cell death was calculated by
comparison of the total LDH released to that released from uninfected
cells lysed with 0.25% Triton X-100 in MEM-lite. The strains lacking
PilT or PilU showed reduced cytotoxicity relative to PAK, causing 44 and 42%, respectively, as much cytotoxicity as the wild type, while a
pilA mutant damaged 36% as many cells as the wild type did
(Fig. 1A). A strain with a defect in
rpoN had even less cytotoxic capability, 16% of the
wild-type level, presumably because of pleiotropic effects on a range
of genes (36). These findings are not the result of
differences in bacterial growth rates since the mutant and wild-type
strains had similar rates of growth in minimal or complex medium (data
not shown). Furthermore, the mutant strains did not achieve wild-type
cytotoxicity even with longer incubation times (up to 11 h; data
not shown).
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Pseudomonas aeruginosa Gene Products
PilT and PilU Are Required for Cytotoxicity In Vitro and Virulence in
a Mouse Model of Acute Pneumonia


![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Strains used

View larger version (14K):
[in a new window]
FIG. 1.
P. aeruginosa pilT and pilU
mutants have decreased ability to damage epithelial cells. Cytotoxicity
of wild-type PAK, hyperpiliated pilT or pilU
mutants, or nonpiliated pilA or rpoN mutants was
assayed by incubation of the bacteria with the cell type indicated.
Cell death was quantitated by LDH release and is expressed as a
percentage of the total LDH released by lysis of cells not exposed to
bacteria. Each assay was performed in triplicate, and error bars
represent SEM. (A) Cytotoxicity of MDCK cells after incubation with
bacteria for 9 h. *, P < 0.003 compared to PAK;
#, P < 0.003 compared to rpoN. (B)
Cytotoxicity observed on A549 cells after incubation with bacteria for
8 h. *, P < 0.001 compared to PAK. (C)
Cytotoxicity observed on HeLa cells after incubation with bacteria for
5 h. *, P < 0.003 compared to PAK; #,
P < 0.05 compared to rpoN. Statistical
analysis was performed by using Student's two-tailed t test
with unequal variance.
PilT and PilU contribute to the association of PAK with epithelial cells. To determine if the loss of the cytotoxic capability of the pilT or pilU mutant corresponded to a defect in adherence to epithelial cells, the association of the mutant strains to the three cell types used was measured. Approximately 107 CFU of each of the various strains (grown and prepared as for the cytotoxicity assays) was incubated with MDCK, A549, or HeLa cells cultured and plated on Transwell filters exactly as described above. Association was assayed by excising the filters (to eliminate bacteria that adhered to plastic) followed by washing the filter-bound cells three times in MEM-lite. The cells were then lysed by treatment with 0.25% Triton X-100 in MEM-lite for 30 min followed by vortexing with glass beads. The bacteria contained within the lysate were quantified by dilution plating on LB agar. Association assays were performed at time points prior to detectable cytotoxicity (3 h for MDCK and A549 cells and 1 h for HeLa cells) to avoid potential bacterial adherence to cell debris. Adherent bacteria were not distinguished from those internalized, but the fraction of internalized bacteria was less than 1% of the fraction of adherent bacteria with all cell types (data not shown). Using this measure, we calculated that 6% of the added wild-type bacteria associated with MDCK monolayers (Fig. 2A), 92% associated with A549 monolayers (Fig. 2B), and 12% associated with HeLa cells (Fig. 2C). The relative binding of PAK to these cell lines is consistent with that previously reported for these cell types (12).
|
PilT and PilU are required for full virulence in a mouse model of acute pneumonia. To assess the contribution of PilT or PilU to P. aeruginosa-induced acute pneumonia, we assayed the virulence of the wild-type and mutant strains in a mouse model of acute pneumonia. Virulence was assessed by two methods, the first using mortality caused by the different isogenic strains as an endpoint and the second measuring the relative ability of the strains to colonize the lung and liver.
For P. aeruginosa-induced mouse mortality, approximately 5 × 107 CFU of bacteria (grown for 17 h in MINS medium [16] at 37°C with shaking and then washed and resuspended in 50 ml of phosphate-buffered saline) were instilled into the nares of methoxyfluorane-anesthetized 6- to 12-week-old BALB/c mice (B&K Laboratories), using a pipette tip. Viable counts were determined by dilution plating on LB plates. For 50% lethal dose calculations, five mice each were infected with twofold dilutions of bacteria. Mice were monitored over the subsequent 7 days in compliance with guidelines of the Animal Care Committee of the University of California, San Francisco. Statistical significance was assigned by the chi-square test. As shown in Fig. 3, none of the 15 mice infected with the PAK wild type survived to the 7-day time point. In contrast, the pilA mutant strain showed little virulence, and 13 of 15 animals survived for the length of the experiment (P < 0.0001). Results with the rpoN mutant were similar in that 14 of 15 mice survived for 7 days (P < 0.0001). These data are in agreement with previously published results for a neonatal mouse model of acute pneumonia which demonstrated a loss of virulence associated with a lack of surface pili (33). Surprisingly, in this assay the virulence of the pilT and pilU mutant strains was statistically indistinguishable from that of the wild type; only 3 of 15 mice receiving pilT and 1 of 15 mice inoculated with pilU survived for the duration of the experiment. The 50% lethal dose of the pilU mutant, the pilT mutant, and PAK differed twofold at most (data not shown).
|
| |
ACKNOWLEDGMENTS |
|---|
We thank members of the Engel laboratory for reading the manuscript and for scientific advice.
This work was supported by grants from the University Wide AIDS Research Program (J.N.E.), the NIH (J.N.E. [R01 AI42806] and A.R.H. [K08 AI001524]), the American Lung Association (J.N.E.), the Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation Fellowship (A.R.H.), the Bank of America-Gianinni Foundation (J.C.C.), the Australian National Health and Medical Research Council (C.B.W. and J.S.M.), and the Australian Research Council (J.S.M.). J.N.E. is a Career Investigator of the American Lung Association.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Disease, Box 0654, University of California, San Francisco, CA 94143-0654. Phone: (415) 476-7355. Fax: (415) 476-9364. E-mail: Jengel{at}medicine.ucsf.edu.
Present address: Department of Bacteriology, University of
Wisconsin, Madison, Madison, WI 53706.
Present address: Department of Microbiology and Immunology,
Northwestern University, Chicago, IL 60611.
§ Present address: Department of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, CA 94143.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alm, R., and J. S. Mattick. 1997. Genes involved in the biogenesis and function of type-4 fimbriae in Pseudomonas aeruginosa. Gene 192:89-98[Medline]. |
| 2. |
Anantha, R. P.,
K. D. Stone, and M. S. Donnenberg.
1998.
Role of BfpF, a member of the PilT family of putative nucleotide-binding proteins, in type IV pilus biogenesis and in interactions between enteropathogenic Escherichia coli and host cells.
Infect. Immun.
66:122-131 |
| 3. | Apodaca, G., M. Bomsel, R. Lindstedt, J. Engel, D. Frank, K. Mostov, and J. Wiener-Kronish. 1995. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation defective host cells are resistant to bacterial killing. Infect. Immun. 63:1541-1551[Abstract]. |
| 4. | Barnett, T. C., S. M. Kirov, M. S. Strom, and K. Sanderson. 1997. Aeromonas spp. possess at least two distinct type IV pilus families. Microb. Pathog. 23:241-247[Medline]. |
| 5. |
Bieber, D.,
S. W. Ramer,
C. Y. Wu,
W. J. Murray,
T. Tobe,
R. Fernandez, and G. K. Schoolnik.
1998.
Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli.
Science
280:2114-2118 |
| 6. | Bradley, D. E. 1974. The adsorption of Pseudomonas aeruginosa pilus-dependent bacteriophages to a host mutant with nonretractile pili. Virology 51:489-492. |
| 7. | Bradley, D. E. 1972. Evidence for the retraction of Pseudomonas aeruginosa RNA phage pili. Biochem. Biophys. Res. Commun. 47:142-149[Medline]. |
| 8. | Bradley, D. E. 1980. A function of Pseudomonas aeruginosa PAO pili: twitching motility. Can. J. Microbiol. 26:146-154[Medline]. |
| 9. | Bradley, D. E. 1972. Shortening of Pseudomonas aeruginosa pili after RNA-phage adsorption. J. Gen. Microbiol. 72:303-319[Medline]. |
| 10. | Bradley, D. E., and T. L. Pitt. 1974. Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J. Gen. Virol. 23:1-15. |
| 11. |
Brossay, L.,
G. Paradis,
R. Fox,
M. Koomey, and J. Hébert.
1994.
Identification, localization, and distribution of the PilT protein in Neisseria gonorrhoeae.
Infect. Immun.
62:2302-2308 |
| 12. |
Chi, E.,
T. Mehl,
D. Nunn, and S. Lory.
1991.
Interaction of Pseudomonas aeruginosa with A549 pneumocyte cells.
Infect. Immun.
59:822-828 |
| 13. |
Farinha, M. A.,
B. D. Conway,
L. M. G. Glasier,
N. W. Ellert,
R. T. Irvin,
R. Sherburne, and W. Paranchych.
1994.
Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice.
Infect. Immun.
62:4118-4123 |
| 14. |
Feldman, M.,
R. Bryan,
S. Rajan,
L. Scheffler,
S. Brunnert,
H. Tang, and A. Prince.
1998.
Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection.
Infect. Immun.
66:43-51 |
| 15. |
Hahn, H. P.
1997.
The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa a review.
Gene
192:99-108[Medline].
|
| 16. | Hauser, A. R., P. J. Kang, and J. Engel. 1998. PepA, a novel secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol. Microbiol. 27:807-818[Medline]. |
| 17. | Hazlett, L. D., M. M. Moon, A. Singh, R. S. Berk, and X. L. Rudner. 1991. Analysis of adhesion, piliation, protease production and ocular infectivity of several P. aeruginosa strains. Curr. Eye Res. 10:351-362[Medline]. |
| 18. | Hobbs, M., and J. S. Mattick. 1993. Common components in the assembly of type 4 fimbriae, DNA transfer systems, filamentous phage and protein-secretion apparatus: a general system for the formation of surface-associated protein complexes. Mol. Microbiol. 10:233-243[Medline]. |
| 19. |
Ishimoto, K. S., and S. Lory.
1989.
Formation of pilin in Pseudomonas aeruginosa requires the alternative factor (RpoN) of RNA polymerase.
Proc. Natl. Acad. Sci. USA
86:1954-1957 |
| 20. | Kang, P. J., A. R. Hauser, G. Apodaca, S. Fleiszig, J. Wiener-Kronish, K. Mostov, and J. N. Engel. 1997. Identification of Pseudomonas aeruginosa genes required for epithelial cell injury. Mol. Microbiol. 24:1249-1262[Medline]. |
| 21. | Kenny, B., R. DeVinney, M. Stein, J. Reinsheid, E. A. Frey, and B. B. Finaly. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-20[Medline]. |
| 22. |
Liles, M. R.,
V. K. Viswanathan, and N. P. Cianciotto.
1998.
Identification and temperature regulation of Legionella pneumophila genes involved in type IV pilus biogenesis and type II protein secretion.
Infect. Immun.
66:1776-1782 |
| 23. | Mattick, J. S., and R. A. Alm. 1995. Common architecture of type 4 fimbriae and complexes involved in macromolecular traffic. Trends Microbiol. 3:411-413. |
| 24. |
Nunn, D.,
S. Bergman, and S. Lory.
1990.
Products of three accessory genes, pilB, pilC, and pilD, are required for biogenesis of Pseudomonas aeruginosa pili.
J. Bacteriol.
172:2911-2919 |
| 25. | Prince, A. 1992. Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract. Microb. Pathog. 13:251-260[Medline]. |
| 26. |
Ramphal, R.,
L. Koo,
K. Ishimoto,
P. A. Totten,
J. C. Lara, and S. Lory.
1991.
Adhesion of Pseudomonas aeruginosa pilin-deficient mutants to mucin.
Infect. Immun.
59:1307-1311 |
| 27. | Sata, H., K. Okinda, and H. Saiton. 1988. Role of pilin in the pathogenesis of Pseudomonas aeruginosa burn infection. Microbiol. Immunol. 32:131-139[Medline]. |
| 28. |
Sawa, T.,
M. Ohara,
K. Kurahashi,
S. Twining,
D. Frank,
D. Doroques,
T. Long,
M. Gropper, and J. Wiener-Kronish.
1998.
In vitro cellular cytotoxicity predicts Pseudomonas aeruginosa virulence in lung infections.
Infect. Immun.
66:3242-3249 |
| 29. | Sohel, K., J. Puente, W. Murray, J. Vuopio-Varkila, and G. Schoolnk. 1993. Cloning and characterization of the bundle-forming pilin gene of enteropathogenic Escherichia coli and its distribution in Salmonella serotypes. Mol. Microbiol. 7:563-575[Medline]. |
| 30. |
Stone, B. J., and Y. Abu Kwaik.
1998.
Expression of multiple pili by Legionella pneumophila: identification and characterization of a type IV pilin gene and its role in adherence to mammalian and protozoan cells.
Infect. Immun.
66:1768-1775 |
| 31. | Stone, K. D., H. Z. Zhang, L. K. Carlson, and M. S. Donnenberg. 1996. A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for the biogenesis of a type IV pilus. Mol. Microbiol. 20:325-337[Medline]. |
| 32. | Strom, M. S., and S. Lory. 1993. Structure-function and biogenesis of the type IV pili. Annu. Rev. Microbiol. 47:565-596[Medline]. |
| 33. | Tang, H., M. Kays, and A. Prince. 1995. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63:1278-1285[Abstract]. |
| 34. | Taylor, R. K., V. L. Miller, D. B. Furlong, and J. J. Mekalanos. 1987. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl. Acad. Sci. USA 84:2822-2837. |
| 35. | Tennent, J. M., and J. S. Mattick. 1994. Type 4 fimbriae, p. 127-146. In P. Klemm (ed.), Fimbriae: aspects of adhesion, genetics, biogenesis and vaccines. CRC Press, Boca Raton, Fla. |
| 36. |
Totten, P. A.,
J. C. Lara, and S. Lory.
1990.
The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene.
J. Bacteriol.
172:389-396 |
| 37. | Walker, J. E., M. Saraste, M. J. Runswick, and N. J. Gay. 1982. Distantly related sequences in the a- and b-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:945-951[Medline]. |
| 38. | Watson, A. A., J. S. Mattick, and R. A. Alm. 1996. Functional expression of heterologous type 4 fimbriae in Pseudomonas aeruginosa. Gene 175:143-150[Medline]. |
| 39. | Whitchurch, C. B., M. Hobbs, S. P. Livingston, V. Krishnapillai, and J. S. Mattick. 1991. Characterization of a Pseudomonas aeruginosa twitching motility gene and evidence for a specialised protein export system widespread in eubacteria. Gene 101:33-44[Medline]. |
| 40. | Whitchurch, C. B., and J. S. Mattick. 1994. Characterization of a gene, pilU, required for twitching motility but not phage sensitivity in Pseudomonas aeruginosa. Mol. Microbiol. 13:1079-1081[Medline]. |
| 40a. | Whitchurch, C. B., and J. S. Mattick. Unpublished data. |
| 41. | Wolfgang, M., P. Lauer, H.-S. Park, L. Brossay, J. Hebert, and M. Koomey. 1998. PilT mutations lead to simultaneous defects in competence for natural transformation and twitching motility in piliated Neisseria gonorrhoeae. Mol. Microbiol. 29:321-330[Medline]. |
| 42. |
Wolfgang, M.,
H. S. Park,
S. F. Hayes,
J. P. van Putten, and M. Koomey.
1998.
Suppression of an absolute defect in type IV pilus biogenesis by loss-of-function mutations in pilT, a twitching motility gene in Neisseria gonorrhoeae.
Proc. Natl. Acad. Sci. USA
95:14973-14978 |
| 43. | Wu, S. S., J. Wu, and D. Kaiser. 1997. The Myxococcus xanthus pilT locus is required for social gliding motility although pili are still produced. Mol. Microbiol. 23:109-121[Medline]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|